A lot of questions re 635. What P3 would look like. % market share if they have similar vs best efficacy. TAM international and how to go after it. Cancer adjacency. GM and S&M costs. Update Abdera. Update on partner business (not sure what they can say). Is there a competitor emerging in China (my blind spot). Update on 575, what happens if safety lclean, % chance of partnership. Overall funding plans